Vaccinology- I: The Vaccine Race

Authors

  • Ibrahim Mohamed Saeed Shnawa Department of Biotechnology College of Biotechnology University of Qasim, Qasim, Babylon, Iraq and Hilla University College, Rarengia, Babylon, Iraq.

DOI:

https://doi.org/10.9734/bpi/mono/978-93-91882-77-8/CH6

Keywords:

Enhancement, herd’ infection, immunity immune overreaction phenomena race simulation, vaccine

Abstract

To combat the pandemic of sars-cov-2 infection cycle vaccines were  prepared and evaluated all over the world. Trails to use them for mass vaccination pre  or during arrival of  the pathogenic pandemic virus to the defined geographic area. For the case of COVID-19 there are numbers of vaccines were developed by different scientific bodies and companies to be trialed through phases I ,II &III all over the globe for emergency use of  different vaccine strategies. As I wrote this lines some of vaccine developer succeed in having emergency license for say number of COVID-19 vaccines all over the world, like Pfizer, Modrena, Synopharm etc….to be applied for mass vaccination.  

Published

2021-08-20

How to Cite

Ibrahim Mohamed Saeed Shnawa. (2021). Vaccinology- I: The Vaccine Race. Immunity to SARS-COV-2 Virus Infections, 46–51. https://doi.org/10.9734/bpi/mono/978-93-91882-77-8/CH6